Document is current

GLP-1 RECEPTOR AGONISTS: EXPANDING INDICATIONS FROM DIABETES AND OBESITY TO CARDIOVASCULAR AND NEURODEGENERATIVE DISEASES

Crossref DOI link: https://doi.org/10.58175/gjrbp.2023.2.4.0225

Published Online: 2023-10-31

Update policy: https://doi.org/10.58175/gsp.ourcrossmarkpolicy